PMEL

PMEL
Name	PMEL
Other names	Pmel17, SILV, gp100, ME20
Organism	Homo sapiens
Length	~661–716 aa
Location	melanosome membrane

PMEL

PMEL is a melanocyte-specific type I transmembrane glycoprotein involved in pigment cell biology and melanosome maturation. Discovered through studies of melanoma immunology and pigmentation genetics, PMEL is essential for melanosomal fibril formation and interacts with multiple trafficking and biogenesis pathways characterized in studies of Melanoma and Albinism. Its biochemical properties have made PMEL a model for studying amyloid formation distinct from pathogenic amyloids like those in Alzheimer's disease and Parkinson's disease.

Introduction

PMEL was identified in investigations of antigenic targets in Melanoma immunotherapy and in genetic analyses of pigmentation mutants from model organisms such as Mouse and Zebra finch. Early work linked PMEL to the melanocyte lineage marker gp100 and to the SILV gene locus studied in Genetics of coat color and Human pigmentation. PMEL's unique ability to form nonpathogenic amyloid fibrils within Melanosome organelles situates it at the intersection of cell biology research in Organelle biogenesis, Protein aggregation, and comparative studies across vertebrates including Chicken, Xenopus, and Danio rerio.

Structure and Genetics

The PMEL polypeptide is synthesized as a type I membrane protein with luminal/extracellular domains that are proteolytically processed into fragments that assemble into fibrils. The primary sequence includes an N-terminal signal peptide, a highly conserved RPT (repeat) domain rich in acidic and amyloidogenic motifs, and a transmembrane helix followed by a short cytosolic tail. Human PMEL maps to chromosome regions identified in linkage studies of pigmentation alongside loci such as MC1R and SLC45A2. Genetic variation in PMEL orthologs has been characterized in Mouse coat color mutants like silver (si) and in domestic species including Horse and Dog, where missense and frameshift alleles alter fibrillogenesis and pigment deposition. Evolutionary conserved cysteine residues and prohormone convertase cleavage sites are documented in comparative genomics analyses involving Ensembl and UCSC Genome Browser resources.

Function and Biological Role

PMEL functions as a scaffold for melanin deposition by forming fibrillar sheets within stage II melanosomes, promoting efficient melanogenesis mediated by enzymes such as Tyrosinase and TYRP1. Through interactions with trafficking complexes including components of the ESCRT machinery and adaptors like AP-3, PMEL is sorted from the trans-Golgi network to early endosomal compartments en route to melanosomes. Proteolytic processing by convertases related to Furin and trafficking chaperones akin to Calnexin and Calreticulin regulate maturation. PMEL fibrils influence melanosome morphology and optical characteristics, with downstream effects observable in studies of pigmentary organs such as the Retina and integumentary systems in Birds and Reptiles.

Clinical Significance and Disorders

Although PMEL itself is not commonly mutated in human systemic disease, alterations in PMEL expression or processing have implications for Melanoma diagnosis and immunotherapy, where gp100-derived peptides serve as targets for T-cell–based vaccines and adoptive cell transfer strategies pioneered in clinical trials at institutions like MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. In veterinary medicine, dominant-negative PMEL mutations produce coat color dilution syndromes in Horse breeds (e.g., the silver dapple phenotype) and ocular anomalies in Dog breeds, paralleling pigmentary defects studied alongside conditions like Oculocutaneous albinism. Experimental PMEL overexpression or misfolding can model intracellular amyloid toxicity relevant to neurodegenerative disease pathways investigated in labs studying Tau and Alpha-synuclein.

Experimental Methods and Research Applications

PMEL is amenable to biochemical, cell biological, and structural approaches: immunohistochemistry with gp100 antibodies is routine in Pathology diagnostics of Melanoma, while electron microscopy reveals fibrillar melanosome ultrastructure in works by investigators affiliated with universities such as Harvard University and University of Oxford. Recombinant expression systems in HEK293 and B16 melanoma cells, CRISPR/Cas9-mediated gene editing employed in laboratories at Broad Institute and Sanger Institute, and in vivo models including PMEL mutant Mouse strains enable mechanistic dissection. Solid-state NMR and cryo-EM studies, often conducted at facilities like EMBL and Max Planck Institute, have characterized PMEL amyloid architecture, informing biomaterials research and synthetic biology applications leveraged by groups at MIT and Stanford University.

Evolution and Comparative Biology

PMEL orthologs are found across jawed vertebrates, with functional conservation of amyloid-forming domains alongside lineage-specific sequence diversification correlated with plumage, scale, and pelage patterns in taxa studied by researchers at institutions such as Smithsonian Institution and Natural History Museum, London. Comparative analyses link PMEL evolution to adaptive coloration in Darwin's finches and selective breeding in domestic species like Chicken and Cow. Phylogenetic studies employing sequences from databases curated by GenBank and analyzed with tools from PhyML and MrBayes trace duplication and diversification events that parallel the evolution of specialized pigment organelles across vertebrate clades.

Category:Proteins